Thursday, 25 May 2017

TNF inhibitor

Datesort ascending Type Title Save
17 May 2017 News Inflammatory Arthritis Stable after Switch to Biosimilar Infliximab
16 May 2017 News NOR-SWITCH Study Validates Biosimilar Use in Multiple Indications
15 May 2017 Slide of the day New TNF Inhibitor Biosimilars
24 Apr 2017 News FDA Approves Renflexis as Second Infliximab Biosimilar
24 Mar 2017 Social RT @DanielHSolomon: MI Risk 39% Lower for Patients With RA Taking TNF Inhibitors https://t.co/7ihHmdNPNy via @medscape
24 Mar 2017 Social Amgens Amjevita (biosimilar of Humira) was approved by EMA for EU use in adult/Peds arthritis IBD, SpA & more https://t.co/O7JBrvtZgE
23 Mar 2017 Social 4 center study of 23 HIV pts shows TNF inhibitors are not assoc w/ higher rates of serious infxn in HIV pts https://t.co/D9R0LByBIJ
15 Mar 2017 Social 1241 PsA TNFi initiations - Persistence predictors include TNFi naive, more skin, prior DMARDs, Mod/High Dz activity https://t.co/WnFj6WtS33
10 Mar 2017 Social 2015 study of 4504 IBD pts shows TNFi use has 2 fold risk of central demyelinating Dz, w/ absolute risk 3.9/10000 PY https://t.co/v0MMvasUic
09 Mar 2017 Social Analysis of FDA FAERS database shows TNF inhibitor ISRs are lower in pts >70yrs & lower when TNFi combined w/ MTX https://t.co/B4t6ivsQDG
08 Mar 2017 Social Case and Review- Etanercept and other TNFi can be safely used to treat HIV positive patients. https://t.co/Ak0YE8XuuO
04 Mar 2017 Social RT @ACRheum: #Biosimilars: What Do Patients Need to Know? Read the Q&A blog post from @AngusWorthing & @ACRSimpleTasks → https://t.co/GP9wC…
03 Mar 2017 Social RT @USBiosimilars: #AAD2017 Surveyed physicians lack understanding of interchangeability. #Biosimilars Forum has info on this concept. http…
17 Feb 2017 Social New Bluetooth device and App to monitor the temperature of your biologic therapy. KEEP IT OUT OF THE VEGGIE CRISPER https://t.co/yghCLkUFIq
17 Feb 2017 Social RT @DrRachelTate: Biosimilars - noninferior in switch trial from IFX and CT-P13 @RheumNow @RWCSmtg https://t.co/bBAaUWHGt1
15 Feb 2017 Social RT @DrRachelTate: Biosimilars - noninferior in switch trial from IFX and CT-P13 @RheumNow @RWCSmtg https://t.co/bBAaUWHGt1
03 Feb 2017 Social infliximab 4 wks before TKA or THA did not increase risk of infection https://t.co/0PPLyNnNP5 @CCalabreseDO @HealioRheum @medpagetoday
31 Jan 2017 News Is the Jury Still Out on Triple Therapy vs. MTX + TNF inhibitor?
24 Jan 2017 Social Janssen has applied to FDA for new indications (AS, PsA) for golimumab based on GO-ALIVE, GO-VIBRANT trials https://t.co/qTZMJtWmya
12 Jan 2017 Social ARTIS #RA registry shows those initiating TNFi within 3 yrs of onset, double their odds of returning to work. https://t.co/WytSlSYRj1